Anthony M. Slater

Epidermal growth factor receptor tyrosine kinase

Walter H.J. Ward, Peter N. Cook, Anthony M. Slater et al. · Biochemical Pharmacology · 1994 · 261 citations

Signal Transduction, Receptor Tyrosine Kinase, Medicine +3

Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate Inhibitor

Siân Rowsell, Paul Hawtin, Claire A. Minshull et al. · Journal of Molecular Biology · 2002 · 255 citations

Crystal Structure, Human Mmp9, Medicine +9

2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted-ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid .kappa. agonists

Gerard Costello, Roger James, John S. Shaw et al. · Journal of Medicinal Chemistry · 1991 · 75 citations · Full text

Combinatorial Chemistry, Organic Chemistry, Pharmacotherapy +19

Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor

M. Raymond V. Finlay, David Buttar, Susan E. Critchlow et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 33 citations · Full text

Drug Target, Biochemistry, Medicine +9

1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives

Robert H. Bradbury, John S. Major, Alexander A. Oldham et al. · Journal of Medicinal Chemistry · 1990 · 17 citations · Full text